Literature DB >> 7831541

Empirical therapy of community-acquired pneumonia.

M S Niederman1.   

Abstract

An empiric approach to the therapy of community-acquired pneumonia (CAP) is needed because of the limitations of traditional approaches to antibiotic selection. The use of sputum Gram's stain and culture tests to guide initial therapy is potentially inaccurate and of limited use. Clinical syndromes cannot be reliably used to predict microbial pathogens, primarily because host, as well as bacterial factors, contribute to the presence of specific clinical signs and symptoms. The routine use of extensive diagnostic testing on all patients with CAP is expensive and of limited clinical usefulness. An empirical approach is presented that is based on an assessment of three factors that can help to predict the likely etiologic pathogens and thus guide initial therapy. These factors are the place of therapy, the presence of advanced age and/or comorbidity, and the severity of illness on initial clinical presentation. When these factors are used to guide empirical therapy, it is important to recognize and appropriately evaluate the nonresponding patient, and it is in this setting that an extensive diagnostic evaluation may be most useful.

Entities:  

Mesh:

Year:  1994        PMID: 7831541

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  6 in total

1.  Reasons for choice of antibiotic for the empirical treatment of CAP by Canadian infectious disease physicians.

Authors:  J Pendergrast; T Marrie
Journal:  Can J Infect Dis       Date:  1999-09

2.  How Nova Scotia general practitioners choose antibiotics for the empirical treatment of community-acquired pneumonia.

Authors:  J Pendergrast; T J Marrie
Journal:  Can J Infect Dis       Date:  2000-11

3.  Etiological diagnosis of pneumonia: A goal worth pursuing?

Authors:  M Antoniou; R F Grossman
Journal:  Can J Infect Dis       Date:  1995-11

4.  Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients.

Authors:  A Porath; F Schlaeffer; N Pick; M Leinonen; D Lieberman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

Review 5.  Management of community-acquired pneumonia in older adults.

Authors:  Antonella F Simonetti; Diego Viasus; Carolina Garcia-Vidal; Jordi Carratalà
Journal:  Ther Adv Infect Dis       Date:  2014-02

6.  The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections.

Authors:  Heinz Burgmann; Bernd Mayer; Arno Lukas; Friedrich Kumbein; Rainer Oberbauer
Journal:  Wien Med Wochenschr       Date:  2003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.